Clinical Trial Update: Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216

View source ↗

Summary

Follow-up study reports antibody responses to hepatitis B, acellular pertussis toxin, and inactivated poliovirus antigens 1 month after the fourth Hexavac vacci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Disease
• Hepatitis B
• Meningococcal Meningitis
• Pertussis
• Poliomyelitis
• Tetanus

Drugs mentioned

• Hexavac (DTPa-HBV-IPV-Hib hexavalent vaccine)
• NeisVac-C (Meningococcal conjugate vaccine against Neisseria meningitidis group C)

Snippet

Sponsor: Pfizer | Conditions: Meningococcal Meninigitis, Serogroup C | Status: COMPLETED